Precision BioSciences Exceeds Expectations with IPO

Precision BioSciences Exceeds Expectations with IPO

Source: 
CP Wire
snippet: 

Genome editing company, Precision BioSciences, raised $126.4 million in its IPO on Wednesday. The company sold 7.9 million shares of stock at a public offering price of $16 per share. When it initially filed for its IPO, the company had hoped to raise $100 million.